Skip to main content
SpringerLink
Log in

Routine urine testing for evidence of drug abuse in workers

The scientific, ethical and legal reasons not to do it

  • Editorials
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Harwood HJ, Napolitano DM, Kristiansen PL, Collins J. Economic costs to society of alcohol and drug abuse and mental illness: 1980. Research Triangle Institute, Research Triangle Park, MC, 1984, RT1/2743/00-01FR

  2. Occupational Safety and Health Reporter, September 17, 1986, p 407

  3. Hansen HJ, Caudill SP, Boone J. Crisis in drug testing: results of CDC blind study. JAMA 1985;253:2382–87

    Article  PubMed  CAS  Google Scholar 

  4. Morgan JP. Problems of mass urine screening for misused drugs. J Psychoact Drugs 1984;16:305–17

    CAS  Google Scholar 

  5. Divoll MK, Greenblatt DJ. The admissibility of positive EMIT results as scientific evidence: counting facts, not heads. J Clin Psychopharmacol 1985;5:114–6

    Article  PubMed  CAS  Google Scholar 

  6. McBay AJ. Problems in testing for abused drugs (letter). JAMA 1986;255:39–40

    Article  PubMed  CAS  Google Scholar 

  7. McBay AJ, Dubowski KM, Fingle BS. Urine testing for marijuana use (letter). JAMA 1983;249:881

    Article  PubMed  CAS  Google Scholar 

  8. Pierce T. Immunoassays as a screening tool for industrial toxicants. J Occup Med 1986;28:589–92

    Article  PubMed  CAS  Google Scholar 

  9. Cone EJ, Johnson RE. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin Pharmacol Ther 1986;40:247–56

    Article  PubMed  CAS  Google Scholar 

  10. Schwartz RH, Hawks RL. Laboratory detection of marijuana use. JAMA 1985;254:788–92

    Article  PubMed  CAS  Google Scholar 

  11. Amnas GJ. Legal aspects of medical confidentiality in the occupational setting. J Occup Med 1976;18:137–40

    Google Scholar 

  12. O’Boyle TF. More firms require employee drug tests. Wall Street Journal, August 8, 1985, p 6

  13. Bompey SH. Drugs in the workplace: from the batter’s box to the boardroom. J Occup Med 1986;28:825–32

    Article  PubMed  CAS  Google Scholar 

  14. Stille A. Drug testing. National Law J 1986;8:1.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Occupational Medicine Program, Department of Medicine, University of Washington, Seattle, Washington

    Linda Rosenstock MD, MPH (Director)

  2. Yale-New Haven Occupational Medicine Program, Yale University, New Haven, Connecticut

    Mark R. Cullen MD (Director)

Authors
  1. Linda Rosenstock MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark R. Cullen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Linda Rosenstock and Mark Cullen are Henry J. Kaiser Family Foundation Faculty Scholars in General Internal Medicine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenstock, L., Cullen, M.R. Routine urine testing for evidence of drug abuse in workers. J Gen Intern Med 2, 135–137 (1987). https://doi.org/10.1007/BF02596314

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02596314

Search

Navigation